Trials / Completed
CompletedNCT01237028
Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will help to show the efficacy of vitamin D and address the optimal strategy to minimize renal injury in IgAN patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcitriol | Calcitriol(1,25-dihydroxycholecalciferol, vitamin D3 analog)0.25 μg per day |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2010-11-09
- Last updated
- 2016-09-07
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01237028. Inclusion in this directory is not an endorsement.